Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18 (Q83925050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

19

Cosette M Wheeler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

27

Kathrin U Jansen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

10

Laura A Koutsky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Luisa L Villa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Kevin A Ault

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Anna R Giuliano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ronaldo L R Costa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Carlos A Petta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Rosires P Andrade

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Darron R Brown

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Alex Ferenczy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Diane M Harper

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Robert J Kurman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Matti Lehtinen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Christian Malm

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sven-Eric Olsson

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Brigitte M Ronnett

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Finn Egil Skjeldestad

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Margareta Steinwall

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Mark H Stoler

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Frank J Taddeo

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jimmy Yu

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Lisa Lupinacci

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Radha Railkar

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Rocio Marchese

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Mark T Esser

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Janine Bryan

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Heather L Sings

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Gretchen M Tamms

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Alfred J Saah

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Eliav Barr

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

15 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

27-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

5571-5583

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

The role of human papillomaviruses in anogenital cancers

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

7 January 2021

Oncogenic DNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Epidemiologic classification of human papillomavirus types associated with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Treatment of anogenital warts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

The health care costs of cervical human papillomavirus--related disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Epidemiology of Genital Human Papillomavirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

External genital warts: diagnosis, treatment, and prevention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16: a 2-year randomized controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

A controlled trial of a human papillomavirus type 16 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Comparative analysis of two rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Prevalence and determinants of HPV infection among Colombian women with normal cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.068

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.04.068

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16753240%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference